Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:106-112
Published online before print November 2, 2006, doi: 10.1161/01.ATV.0000251517.98396.4a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/1/106    most recent
01.ATV.0000251517.98396.4av2
01.ATV.0000251517.98396.4av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, M. K.C.
Right arrow Articles by Cooke, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, M. K.C.
Right arrow Articles by Cooke, J. P.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:106.)
© 2007 American Heart Association, Inc.


Vascular Biology

A Central Role for Nicotinic Cholinergic Regulation of Growth Factor–Induced Endothelial Cell Migration

Martin K.C. Ng; Jenny Wu; Edwin Chang; Bing-yin Wang; Regina Katzenberg-Clark; Akiko Ishii-Watabe; John P. Cooke

From the Department of Medicine (M.K.C.N., J.W., E.C., B.-y.W., R.K.-C., A.I.-W., J.P.C.), Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif.; and the Department of Cardiology (M.K.C.N.), Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Correspondence to John P. Cooke, Falk Cardiovascular Research Center, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5406. E-mail john.cooke{at}stanford.edu

Objective— An endothelial nicotinic acetylcholine receptor (nAChR) participates in atherogenesis and tumorigenesis by promoting neovascularization. To date, the mechanisms of nAChR-mediated angiogenesis and their relationship to angiogenic factors, eg, VEGF and bFGF, are unknown.

Methods and Results— Nicotine induced dose-dependent human microvascular endothelial cell (HMVEC) migration, a key angiogenesis event, to an extent which was equivalent in magnitude to bFGF (10 ng/mL) but less than for VEGF (10 ng/mL). Unexpectedly, nAChR antagonism not only abolished nicotine-induced HMVEC migration but also abolished migration induced by bFGF and attenuated migration induced by VEGF. Transcriptional profiling identified gene expression programs which were concordantly regulated by all 3 angiogens (nicotine, VEGF, and bFGF), a notable feature of which includes corepression of thioredoxin-interacting protein (TXNIP), endogenous inhibitor of the redox regulator thioredoxin. Furthermore, TXNIP repression by all 3 angiogens induced thioredoxin activity. Silencing thioredoxin by small interference RNA abrogated all angiogen-induced migration while silencing TXNIP strongly induced HMVEC migration. Interestingly, nAChR antagonism abrogates growth factor (VEGF and bFGF)–mediated induction of thioredoxin activity.

Conclusions— Nicotine promotes angiogenesis via stimulation of nAChR-dependent endothelial cell migration. Furthermore, growth factor–induced HMVEC migration, a key angiogenesis event, requires nAChR activation—an effect mediated in part by nAChR-dependent regulation of thioredoxin activity.

Nicotine induces nicotinic acetylcholine receptor (nAChR)–dependent endothelial cell migration (ECM). nAChR antagonism also suppresses bFGF- and VEGF-induced ECM. ECM induced by nicotine, VEGF, or bFGF requires nAChR-dependent induction of thioredoxin activity via repression of the thioredoxin inhibitor, TXNIP. Therefore growth factor–induced ECM, a key angiogenesis event, requires nAChR activation.


Key Words: nicotine • angiogenesis • endothelium • vascular endothelial growth factor • fibroblast growth factor




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. S. Celermajer and M. K.C. Ng
Where there's smoke...
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1772 - 1774.
[Full Text] [PDF]


Home page
IOVSHome page
K. Kiuchi, M. Matsuoka, J. C. Wu, R. Lima e Silva, M. Kengatharan, M. Verghese, S. Ueno, K. Yokoi, N. H. Khu, J. P. Cooke, et al.
Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1705 - 1711.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. P. Sieveking, A. Buckle, D. S. Celermajer, and M. K.C. Ng
Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.
J. Am. Coll. Cardiol., February 12, 2008; 51(6): 660 - 668.
[Abstract] [Full Text] [PDF]